论文部分内容阅读
病毒酶抑制剂的研究已经在抗病毒药物的筛选中受到重视,成为抗病毒化疗的新途径。与此同时,联合化疗在实验性抗疱疹、流感和肝炎等病毒方面也显示出良好的效果,其主要优点在于减少药物毒性和避免耐药株的产生。近来用特异性抗体或脂质体等物质作为抗病毒药物载体的抗病毒导向疗法也正在引起关注。其主要优点是产生特异性抗病毒作用,克服药物毒性和增强疗效。
The research of virus enzyme inhibitors has been paid more attention in the screening of antiviral drugs and become a new way of antiviral chemotherapy. In the meantime, combination chemotherapy also shows good results in the testing of anti-herpes, flu and hepatitis viruses, with the main advantages of reducing drug toxicity and avoiding the development of drug-resistant strains. Recently, the use of specific antibodies or liposomes and other substances as anti-viral drug carrier antiviral therapies are also cause for concern. Its main advantage is to produce a specific antiviral effect, to overcome drug toxicity and enhance efficacy.